The research undertaken within ANTC is focused on three key areas to advance brain-based ATMP development with the aim of improving the lives of people living with neurodegenerative conditions like Huntington’s and Parkinson’s diseases.
- Delivering ATMPs to the human brain in early phase clinical trials
Read more - Supporting ATMP development and evaluation for neurological disease
Read more - Using people’s lived experience to improve how our trials are designed
Read more